Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy
We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, β-lactams, β-lactam/β-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2005-04, Vol.40 (7), p.e67-e68 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e68 |
|---|---|
| container_issue | 7 |
| container_start_page | e67 |
| container_title | Clinical infectious diseases |
| container_volume | 40 |
| creator | Wareham, D. W. Wilks, M. Ahmed, D. Brazier, J. S. Millar, M. |
| description | We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, β-lactams, β-lactam/β-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections. |
| doi_str_mv | 10.1086/428623 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67728486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>823877011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-fa67ad18e6fb3dba11cec2bd12f16318ef60fd8df00c59bd2072330bbff579733</originalsourceid><addsrcrecordid>eNqFkcluFDEURS0EIiHAJyCLBbsKHspDsQvNkKBugaARiI3l8tBxcJcLu0qQbPnxOHSLSGxY2bo-OvJ7F4DHGB1jJPnzlkhO6B1wiBkVDWcdvlvviMmmlVQegAelXCCEsUTsPjjATJK2E_IQ_D4ZtMupDwZ-cmMJBb6aHZwSXM1xCjbPm-ajq_Gkhwm-1GaqcLCuQJ_1JsRQXsBVMDeCFNMmGB3hYs4O6sHCRQzDn6QaxjQUB3-G6Rwuw-CuUgwWrs9d1uPlQ3DP61jco_15BD6_eb1enDbL92_PFifLxlBBp8ZrLrTF0nHfU9trjI0zpLeYeMxpzT1H3krrETKs6y1BglCK-t57JjpB6RF4tvOOOf2YXZnUNhTjYtSDS3NRXAgiW8n_C2JRl91JXMGn_4AXac5DHUIR3HUctx27tdU1lZKdV2MOW50vFUbqpjy1K6-CT_a2ud86e4vt26pAswNqH-7X33edv9e_U8HU6ddv6suatu_oh5Wi9Bo2r6R1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219961495</pqid></control><display><type>article</type><title>Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Wareham, D. W. ; Wilks, M. ; Ahmed, D. ; Brazier, J. S. ; Millar, M.</creator><creatorcontrib>Wareham, D. W. ; Wilks, M. ; Ahmed, D. ; Brazier, J. S. ; Millar, M.</creatorcontrib><description>We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, β-lactams, β-lactam/β-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/428623</identifier><identifier>PMID: 15824978</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Acetamides - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Bacteroides fragilis ; Bacteroides fragilis - physiology ; Bacteroides Infections - microbiology ; Drug Resistance, Multiple, Bacterial ; Female ; Humans ; Linezolid ; Microbial Sensitivity Tests ; Middle Aged ; Oxazolidinones - therapeutic use ; Sepsis - drug therapy ; Sepsis - microbiology</subject><ispartof>Clinical infectious diseases, 2005-04, Vol.40 (7), p.e67-e68</ispartof><rights>Copyright National Library of Medicine - MEDLINE Abstracts Apr 1 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-fa67ad18e6fb3dba11cec2bd12f16318ef60fd8df00c59bd2072330bbff579733</citedby><cites>FETCH-LOGICAL-c373t-fa67ad18e6fb3dba11cec2bd12f16318ef60fd8df00c59bd2072330bbff579733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15824978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wareham, D. W.</creatorcontrib><creatorcontrib>Wilks, M.</creatorcontrib><creatorcontrib>Ahmed, D.</creatorcontrib><creatorcontrib>Brazier, J. S.</creatorcontrib><creatorcontrib>Millar, M.</creatorcontrib><title>Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, β-lactams, β-lactam/β-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections.</description><subject>Acetamides - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteroides fragilis</subject><subject>Bacteroides fragilis - physiology</subject><subject>Bacteroides Infections - microbiology</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Female</subject><subject>Humans</subject><subject>Linezolid</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Oxazolidinones - therapeutic use</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - microbiology</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcluFDEURS0EIiHAJyCLBbsKHspDsQvNkKBugaARiI3l8tBxcJcLu0qQbPnxOHSLSGxY2bo-OvJ7F4DHGB1jJPnzlkhO6B1wiBkVDWcdvlvviMmmlVQegAelXCCEsUTsPjjATJK2E_IQ_D4ZtMupDwZ-cmMJBb6aHZwSXM1xCjbPm-ajq_Gkhwm-1GaqcLCuQJ_1JsRQXsBVMDeCFNMmGB3hYs4O6sHCRQzDn6QaxjQUB3-G6Rwuw-CuUgwWrs9d1uPlQ3DP61jco_15BD6_eb1enDbL92_PFifLxlBBp8ZrLrTF0nHfU9trjI0zpLeYeMxpzT1H3krrETKs6y1BglCK-t57JjpB6RF4tvOOOf2YXZnUNhTjYtSDS3NRXAgiW8n_C2JRl91JXMGn_4AXac5DHUIR3HUctx27tdU1lZKdV2MOW50vFUbqpjy1K6-CT_a2ud86e4vt26pAswNqH-7X33edv9e_U8HU6ddv6suatu_oh5Wi9Bo2r6R1</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Wareham, D. W.</creator><creator>Wilks, M.</creator><creator>Ahmed, D.</creator><creator>Brazier, J. S.</creator><creator>Millar, M.</creator><general>The University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy</title><author>Wareham, D. W. ; Wilks, M. ; Ahmed, D. ; Brazier, J. S. ; Millar, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-fa67ad18e6fb3dba11cec2bd12f16318ef60fd8df00c59bd2072330bbff579733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acetamides - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteroides fragilis</topic><topic>Bacteroides fragilis - physiology</topic><topic>Bacteroides Infections - microbiology</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Female</topic><topic>Humans</topic><topic>Linezolid</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Oxazolidinones - therapeutic use</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wareham, D. W.</creatorcontrib><creatorcontrib>Wilks, M.</creatorcontrib><creatorcontrib>Ahmed, D.</creatorcontrib><creatorcontrib>Brazier, J. S.</creatorcontrib><creatorcontrib>Millar, M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wareham, D. W.</au><au>Wilks, M.</au><au>Ahmed, D.</au><au>Brazier, J. S.</au><au>Millar, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>40</volume><issue>7</issue><spage>e67</spage><epage>e68</epage><pages>e67-e68</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, β-lactams, β-lactam/β-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>15824978</pmid><doi>10.1086/428623</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2005-04, Vol.40 (7), p.e67-e68 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67728486 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals |
| subjects | Acetamides - therapeutic use Anti-Bacterial Agents - therapeutic use Bacteroides fragilis Bacteroides fragilis - physiology Bacteroides Infections - microbiology Drug Resistance, Multiple, Bacterial Female Humans Linezolid Microbial Sensitivity Tests Middle Aged Oxazolidinones - therapeutic use Sepsis - drug therapy Sepsis - microbiology |
| title | Anaerobic Sepsis Due to Multidrug-Resistant Bacteroides fragilis: Microbiological Cure and Clinical Response with Linezolid Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T20%3A44%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anaerobic%20Sepsis%20Due%20to%20Multidrug-Resistant%20Bacteroides%20fragilis:%20Microbiological%20Cure%20and%20Clinical%20Response%20with%20Linezolid%20Therapy&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Wareham,%20D.%20W.&rft.date=2005-04-01&rft.volume=40&rft.issue=7&rft.spage=e67&rft.epage=e68&rft.pages=e67-e68&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/428623&rft_dat=%3Cproquest_cross%3E823877011%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219961495&rft_id=info:pmid/15824978&rfr_iscdi=true |